IL6 and neoplasm: Within the tumor microenvironment, IL-6 facilitates the infiltration of inflammation-induced CD8+ T cells [98,99] and cell-based models of NED and CRPC have been induced by IL-6 treatment in which PHF8 was found to be downregulated during NED and upregulated in CRPC [73].